Published Date:2022-01-20 Original Link:https://www.onenessbio.com/en/news_detail138_4.htm No 1 Date of announcement 2022/01/20 Time of announcement 16:23:01 Subject Oneness Biotech Co., Ltd. receives a European patent on the producing recombinant glycoproteins with modified glycosylation. To which item it meets paragraph 53 Date of events 2022/01/20 Statement Date of occurrence of the event:2022/01/20 Company name:ONENESS BIOTECH CO., LTD. Relationship...Read More
Published Date:2022-01-19 Original Link:https://www.onenessbio.com/en/news_detail137_4.htm No 1 Date of announcement 2022/01/19 Time of announcement 17:09:48 Subject Oneness Biotech Co., Ltd. receives a Canadian patent on FB704A, an anti-IL6 fully-human antibody new drug. To which item it meets paragraph 53 Date of events 2022/01/19 Statement Date of occurrence of the event:2022/01/19 Company name:ONENESS BIOTECH CO., LTD. Relationship...Read More
Published Date:2022-01-11 Original Link:https://www.onenessbio.com/en/news_detail136_4.htm No 1 Date of announcement 2022/01/11 Time of announcement 17:00:43 Subject A Hongkong patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted. To which item it meets paragraph 53 Date of events 2022/01/11 Statement Date of occurrence of the event:2022/01/11 Company name:ONENESS BIOTECH CO.,...Read More
Published Date:2022-01-04 Original Link:https://www.onenessbio.com/en/news_detail135_4.htm No 1 Date of announcement 2022/01/04 Time of announcement 18:45:45 Subject Oneness Biotech to Present at the 40th Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2022/01/12 Statement Date of institutional investor conference: 2022/01/12 Time of institutional investor conference: 23:00 (CST) Location of institutional...Read More
Published Date:2022-01-03 Original Link:https://www.onenessbio.com/en/news_detail134_4.htm No 1 Date of announcement 2022/01/03 Time of announcement 16:56:12 Subject Clarification on the media report with regards to the donation by Oneness founder To which item it meets paragraph 8 Date of events 2022/01/03 Statement Date of occurrence of the event:2022/01/03 Company name:Oneness Biotech Co., Ltd. Relationship to the Company...Read More
Published Date:2021-12-30 Original Link:https://www.onenessbio.com/en/news_detail133_1.htm No 2 Date of announcement 2021/12/30 Time of announcement 17:26:58 Subject Annouce the change of the spokesperson. To which item it meets paragraph 8 Date of events 2021/12/30 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting...Read More
Published Date:2021-12-30 Original Link:https://www.onenessbio.com/en/news_detail132_1.htm No 1 Date of announcement 2021/12/30 Time of announcement 17:22:03 Subject Oneness announces the information about the investor’s conference of 2021 Q4. To which item it meets paragraph 6 Date of events 2021/12/30 Statement Date of the board of directors resolution or date of occurrence of the change:2021/12/30 Position (Please enter...Read More
Published Date:2021-12-22 Original Link:https://www.onenessbio.com/en/news_detail131_1.htm No 1 Date of announcement 2021/12/17 Time of announcement 16:33:29 Subject Oneness announces the information about the investor’s conference of 2021 Q4. To which item it meets paragraph 12 Date of events 2021/12/29 Statement Date of institutional investor conference:2021/12/29 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More
Published Date:2021-12-17 Original Link:https://www.onenessbio.com/en/news_detail130_1.htm No 1 Date of announcement 2021/12/17 Time of announcement 17:37:36 Subject The Singapore Health Science Authority has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 53 Date of events 2021/12/17 Statement 1.Product:ON101 Diabetic foot ulcer new drug 2.Mass...Read More
Published Date:2021-12-16 Original Link:https://www.onenessbio.com/en/news_detail129_1.htm No 1 Date of announcement 2021/12/16 Time of announcement 17:19:51 Subject Oneness Biotech Co., LTD. receives “Prior Authorisation for Import of Traditional Medicines” from Macau on Fespixon cream (Research code: ON101) To which item it meets paragraph 53 Date of events 2021/12/16 Statement 1.Date of occurrence of...Read More